期刊文献+

The clinical analysis of secondary hypertension patients

The clinical analysis of secondary hypertension patients
下载PDF
导出
摘要 Objective To analyze the situation of secondary hypertension caused by different etiology and its treatment status so as to improve its treatment.Methods Totally 580 patients with secondary hypertension selected with strict criteria were divided into 4 groups in accordance with the etiology.The data were dealt with SPSS 13.0.We analyzed the sex,age,systolic pressure,diastolic pressure and positive incidence of family history of all the secondary hypertension patients in each group,and compared their usage of every unilateral preparation.Results The average age of renal parenchymal disease was more advanced than that of adrenal disease and other diseases.The administration of diuretics and angiotensin-converting enzyme inhibitor(ACEI)in renal parenchymal disease group,αβ receptor blocking agents and calcium antagonists in kidney-artery disease group,α antagonists in adrenal disease and compound antihypertensive agents in other diseases groups all affected advantage of the ratio.Conclusion Diuretics and ACEI are suitable for hypertension caused by renal parenchymal disease.αβ receptor blocking agents and calcium antagonists are suitable for that caused by kidney artery disease,but α receptor blocking agents are suitable for that caused by adrenal disease. Objective To analyze the situation of secondary hypertension caused by different etiology and its treatment status so as to improve its treatment.Methods Totally 580 patients with secondary hypertension selected with strict criteria were divided into 4 groups in accordance with the etiology.The data were dealt with SPSS 13.0.We analyzed the sex,age,systolic pressure,diastolic pressure and positive incidence of family history of all the secondary hypertension patients in each group,and compared their usage of every unilateral preparation.Results The average age of renal parenchymal disease was more advanced than that of adrenal disease and other diseases.The administration of diuretics and angiotensin-converting enzyme inhibitor(ACEI)in renal parenchymal disease group,αβ receptor blocking agents and calcium antagonists in kidney-artery disease group,α antagonists in adrenal disease and compound antihypertensive agents in other diseases groups all affected advantage of the ratio.Conclusion Diuretics and ACEI are suitable for hypertension caused by renal parenchymal disease.αβ receptor blocking agents and calcium antagonists are suitable for that caused by kidney artery disease,but α receptor blocking agents are suitable for that caused by adrenal disease.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2009年第4期267-271,共5页 药物分析学报(英文版)
关键词 secondary hypertension rational drug selection advantage of the ratio secondary hypertension rational drug selection advantage of the ratio
  • 相关文献

参考文献11

  • 1Carolina C. Gonzaga,David A. Calhoun.Resistant hypertension and hyperaldosteronism[J].Current Hypertension Reports.2008(6)
  • 2Hu DY.Diagnosis and treat ment of renal artery stenosis[].Chinese Medical Journal.2007
  • 3Zeng WT,Tan JQ.Treat ment strategies for secondary hyper-tension[].New Med.2008
  • 4Zeng LY,Mu PW.Status quo of diagnosis and treat ment of primary aldosteronis m[].New Med.2004
  • 5Wu PS.Clinical application of fixed compound antihypertens-ive agents[].Chin J Geriatr.2004
  • 6Zhao J,,Dang AM.The diagnosis ideas on secondary hyper-tension[].Chin Commun Physicians.2007
  • 7Calhoun DA,Jones D,Textor S,et al.Resistant hyperten-sion:diagnosis,evaluation,and treat ment—a scientific state-ment fromthe American Heart Association Professional Edu-cation Committee of the Council for High Blood Pressure Re-search[].Circulation.2008
  • 8Acelajado MC,Calhoun DA.Resistant hypertension:who and howto evaluate[].Current Opinion in Cardiology.2009
  • 9Xu WL,Liu WS.Case analysis on57misdiagnosis of seconda-ry hypertension[].Clin Misdiagn Mistreat.2008
  • 10White CJ,Olin J W.Diagnosis and management of atheroscle-rotic renal artery stenosis:improving patient selection and out-comes[].Nat Clin Pract Cardiovasc Med.2009

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部